Corporate News 25-May-19
Venus Remedies director resigns
With effect from 24 May 2019
Venus Remedies announced the resignation of Dr. Rupinder Tewari, Non- Executive Independent Director of the Company has tendered his resignation from the Board of the Company w.e.f. 24 May 2019 due to professional occupancy.
Previous News
Venus Remedies launches Elores drug in Oman
( Hot Pursuit - 17-Aug-23 12:46 )
Venus Remedies schedules board meeting
( Corporate News - 03-Feb-24 17:07 )
Venus Remedies to discuss results
( Corporate News - 03-Aug-24 10:11 )
Venus Remedies schedules board meeting
( Corporate News - 21-May-24 11:52 )
Venus Remedies announces board meeting date
( Corporate News - 01-Aug-19 11:13 )
Venus Remedies to declare Quarterly Result
( Corporate News - 30-Oct-23 16:02 )
Venus Remedies reports standalone net loss of Rs 0.25 crore in the December 2015 quarter
( Results - Announcements 11-Feb-16 16:43 )
Venus Remedies net profit declines 23.20% in the March 2013 quarter
( Results - Announcements 20-May-13 11:10 )
Venus Remedies consolidated net profit rises 86.49% in the September 2023 quarter
( Results - Announcements 10-Nov-23 11:09 )
Venus Remedies spurts on securing PLI nod for pharmaceutical goods in India
( Hot Pursuit - 09-Dec-21 09:34 )
Venus Remedies jumps on pact with Teva for anti-cancer drug
( Hot Pursuit - 27-Aug-14 12:56 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
